Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate
- PMID: 2895936
- DOI: 10.1007/BF00174677
Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate
Abstract
Seventeen outpatients were treated with depot neuroleptics, zuclopenthixol decanoate in Viscoleo or fluphenazine decanoate in sesame oil, with dosage intervals of 3 weeks. During the 4th, 6th, and 8th dosage interval blood samples were drawn in oxalated tubes. Plasma concentrations of the active neuroleptic drugs, zuclopenthixol and fluphenazine, were determined by high performance liquid chromatography. The concentrations indicated some interindividual as well as intraindividual variations. For zuclopenthixol the maximum concentration was most often seen at day 7 after injection, whereas the kinetics of the fluphenazine concentrations was more variable. There was an indication of more fluctuation in the 4th dosage interval than in the 8th dosage interval, possibly due to the fact that steady state has not yet been achieved at the 4th dosage interval.
Similar articles
-
Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.Psychopharmacology (Berl). 1984;83(2):147-50. doi: 10.1007/BF00429723. Psychopharmacology (Berl). 1984. PMID: 6146995 Clinical Trial.
-
A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.Pharmatherapeutica. 1983;3(5):289-93. Pharmatherapeutica. 1983. PMID: 6133287 Clinical Trial.
-
Pharmacokinetics of three different injectable zuclopenthixol preparations.Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(1-2):77-85. doi: 10.1016/0278-5846(89)90005-5. Prog Neuropsychopharmacol Biol Psychiatry. 1989. PMID: 2568662
-
Clinical pharmacokinetics of the depot antipsychotics.Clin Pharmacokinet. 1985 Jul-Aug;10(4):315-33. doi: 10.2165/00003088-198510040-00003. Clin Pharmacokinet. 1985. PMID: 2864156 Review.
-
Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.J Psychiatry Neurosci. 1994 Jul;19(4):254-64. J Psychiatry Neurosci. 1994. PMID: 7918346 Free PMC article. Review.
Cited by
-
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview.CNS Drugs. 2021 Jan;35(1):39-59. doi: 10.1007/s40263-020-00779-5. Epub 2021 Jan 28. CNS Drugs. 2021. PMID: 33507525 Free PMC article. Review.
-
Zuclopenthixol dihydrochloride for schizophrenia.Cochrane Database Syst Rev. 2017 Nov 16;11(11):CD005474. doi: 10.1002/14651858.CD005474.pub2. Cochrane Database Syst Rev. 2017. PMID: 29144549 Free PMC article.
-
[Long-acting injectable antipsychotics. Overview and advice for daily routine care].Nervenarzt. 2014 Sep;85(9):1067-74. doi: 10.1007/s00115-013-3842-4. Nervenarzt. 2014. PMID: 24113854 Review. German.
-
Using in silico methods to determine optimal tapering regimens for decanoate-based long-acting injectable psychosis drugs.Ther Adv Psychopharmacol. 2024 Sep 12;14:20451253241272790. doi: 10.1177/20451253241272790. eCollection 2024. Ther Adv Psychopharmacol. 2024. PMID: 39282238 Free PMC article.
-
Fluphenazine decanoate (depot) and enanthate for schizophrenia.Cochrane Database Syst Rev. 2015 Feb 5;2015(2):CD000307. doi: 10.1002/14651858.CD000307.pub2. Cochrane Database Syst Rev. 2015. PMID: 25654768 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources